Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

‘Vast Majority’ Of Antibac Soaps Need Reformulation Under FDA Final Rule

Executive Summary

FDA says the “vast majority” of roughly 2,100 consumer antibacterial soaps on the market contain at least one of 19 antimicrobial ingredients banned from OTC use under new final rule. Industry, which suggests the agency is overstating the rule’s impact, is focused on delivering supporting data for three active ingredients still pending before FDA for GRASE use in the category.

Advertisement

Related Content

FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review
FDA Rule Marks Consumer Antibac Soaps A Possible Endangered Species
FDA Rule Marks Consumer Antibac Soaps A Possible Endangered Species
FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling

Topics

Advertisement
UsernamePublicRestriction

Register